|
|
|
Dear Drug Discovery Enthusiast,
We thought this might be interesting for you:
|
|
| |
Free Webinar: EST Timezone Workshop on Kinase Ligand Design
We have received numerous requests for a live demonstration tailored to North America for our recent kinase ligand design workshop. With such a popular demand, we are excited to announce a "workshop encore" for our USA audience.
This BioSolveIT workshop is dedicated to elucidating the basic design of selective kinase inhibitors, as well as the application of advanced techniques to optimize lead structures. Encompassing both 3D structure-based and 2D ligand-based realms, we will present and discuss several examples that inspire generation of new ideas for hinge binders and adjacent core regions. Methods will include fragment-based growing and evolution (FBDD), scaffold hopping, Chemical Space exploration (involving trillions of possibilities), and various other strategies facilitated by BioSolveIT tools.
Drug discovery beginners, veterans, and medicinal chemistry enthusiasts are invited to join this highly informative workshop and the subsequent discussion.
| Presented by: |
|
Dr. Alexander Neumann, BioSolveIT, Germany |
| Date/time: |
|
Thursday, February 29th, 19:00 CET (Berlin) |
|
|
| |
New Make-On-Demand Chemical Space: AMBrosia — 110,496,278,572 Drug-Like Compounds
We are excited to announce a new Chemical Space featuring over 110 billion drug-like compounds: AMBrosia by Ambinter (a brand of Greenpharma) is the latest addition to the ultra-large screenable Chemical Spaces lineup from BioSolveIT. This molecule collection contains tangible compounds based on in-house chemistry and knowledge that can conveniently be ordered and delivered to you within few weeks.
Located in France, Greenpharma is a valuable and reliable partner to accelerate your R&D process by expanding your hunting grounds with high quality compounds for screening and novel IP for ideation.
Save time and resources by diving into a another new dimension of relevant chemistry.
|
|
| |
Scientific Challenge Deadline: February 22nd, 2024
Have you always wanted to go wild with drug discovery? Now you can! Come achieve great results with BioSolveIT's drug discovery platforms and tools.
Simply apply to our Scientific Challenge with your unique drug discovery proposal. Tell us how you would implement our applications into your workflow.
The best candidates receive a 1-year license of our complete product portfolio, and the overall best project will be honored with a 1,000€ research grant to support their work.
Submission deadline is February 22nd, 2024.
|
|
| |
|
Hope to (virtually) see you soon!
Your BioSolve-rs
|
|
| |
|
|
| |
BioSolveIT GmbH
An der Ziegelei 79
53757 St. Augustin
Germany
|
www.biosolveit.de
+49-2241-25250
Amtsgericht Siegburg, HRB 6261
Geschäftsführer: Dr. Christian Lemmen
|
|
|